Printer Friendly

Radiesse approved.

Last December, the Food and Drug Administration (FDA) approved Radiesse, an injectable filler to correct signs of facial lipoatrophy (loss of fat) in HIV+ people. Until now, Sculptra was the only facial filler approved by the FDA for this condition. Radiesse contains a synthetic (or man-made) version of calcium hydroxylapatite, a substance found in bones and teeth. When Radiesse is injected into the skin, natural collagen forms around the calcium hydroxylapatite. As a result, the skin becomes thicker and conceals the hollows in the thee associated with lipoatrophy. Common side effects include bruising, swelling, pain, and redness at the injection side, which are usually temporary and mild in nature. There is also the small possibility of infection at the injection site. Radiesse is considered to be a temporary filler and treatment may need to be repeated within a tow years to maintain results.
COPYRIGHT 2007 The Center for AIDS: Hope & Remembrance Project
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:treatment news
Publication:HIV Treatment: ALERTS!
Date:Jun 1, 2007
Previous Article:Anemia treatment warnings.
Next Article:Definitions.

Related Articles
Injectable implant.
Injectable vocal fold implant.
Injectable vocal fold implant.
Injectable vocal fold implants.
Injectable vocal fold implants.
Long-lasting injectable implant * for correcting cosmetic nasal deformities.
Hyaluronic acid spreader-graft injection for internal nasal valve collapse.

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |